Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013140
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental development, education and training, and science and technology advice. It conducts research in the areas of acoustics, astronomy, automation, biophysics, botany, chemistry, electronics, environmental sciences, geographical sciences and natural resources, geology and geophysics, mathematics, mechanics, microbiology, nano science and technology, physics, psychology, semiconductors, software, systems sciences, theoretical physics, and zoology. CAS promotes strategic partnerships with first-rate research institutions, international science organizations and multinational research and development corporations. The institute has operations in Beijing, Changchun, Chengdu, Guangzhou, Kunming, Lanzhou, Nanjing, Shanghai, Shenyang, Wuhan, Xi’an, and Xinjiang. CAS is headquartered in Beijing, China.

Chinese Academy of Sciences – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Chinese Academy of Sciences, Medical Devices Deals, 2011 to YTD 2017 9
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 11
MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 12
Licensing Agreements 13
Innovent Biologics Enters into Licensing Agreement with Chinese Academy and Shanghai Institute of Organic 13
RaQualia Pharma to Enter into Licensing Agreement with Chinese Academy of Sciences and Guangzhou Great Water Tech 14
MicroConstants Enters into Licensing Agreement with Institute of Biophysics, Chinese Academy of Sciences 15
Chinese Academy of Sciences – Key Competitors 16
Chinese Academy of Sciences – Key Employees 17
Chinese Academy of Sciences – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Sep 07, 2016: Sugar Transforms a Traditional Chinese Medicine into a Cruise Missile 20
Aug 19, 2016: Chinese researchers reveal redox sensor protein role in pathogenic mycobacteria 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Chinese Academy of Sciences, Deals By Therapy Area, 2011 to YTD 2017 8
Chinese Academy of Sciences, Medical Devices Deals, 2011 to YTD 2017 9
Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 11
MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 12
Innovent Biologics Enters into Licensing Agreement with Chinese Academy and Shanghai Institute of Organic 13
RaQualia Pharma to Enter into Licensing Agreement with Chinese Academy of Sciences and Guangzhou Great Water Tech 14
MicroConstants Enters into Licensing Agreement with Institute of Biophysics, Chinese Academy of Sciences 15
Chinese Academy of Sciences, Key Competitors 16
Chinese Academy of Sciences, Key Employees 17
Chinese Academy of Sciences, Subsidiaries 18
Chinese Academy of Sciences, Joint Venture 19

★海外企業調査レポート[Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dare Bioscience Inc (DARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Vattenfall:企業の戦略・SWOT・財務情報
    Vattenfall - Strategy, SWOT and Corporate Finance Report Summary Vattenfall - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Aurora Energy Pty Ltd:企業の戦略的SWOT分析
    Aurora Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SPIE SA (SPIE):企業の財務・戦略的SWOT分析
    SPIE SA (SPIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務分析
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BrightSpring Health Services:企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software products, services and solutions. The company’s product portfolio consists of NFV virtualization platforms, operating systems, device and network management, traffic intelligence, 5g data management, access management and policy c …
  • Sanshin Electronics Co., Ltd.:企業の戦略・SWOT・財務分析
    Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Qurient Co Ltd (115180)-製薬・医療分野:企業M&A・提携分析
    Summary Qurient Co Ltd (Qurient) is a biotechnology company that focuses on the development of new drugs for unmet medical needs. The company’s portfolio of pipeline products includes Q301, Q203, Q701, 5LO INH and CDK7 INH among others. The company is developing products for the treatment of atopic …
  • Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Enerplus Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resour …
  • Progenics Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mercuria Energy Group Ltd:企業の戦略的SWOT分析
    Mercuria Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a healthcare products company that offers drug discovery services. The company develops and discovers pharmaceuticals targeting infectious diseases. It identifies new classes of antibiotic agents use a novel mechanism of bactericidal action differe …
  • Cara Therapeutics Inc (CARA)-医療機器分野:企業M&A・提携分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a clinical-stage biotechnology company that develops novel therapeutics for pain and inflammation and pruritus. The company products include kappa receptor agonists and cannabinoid receptors. It offers products for therapeutic areas which include …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆